The resected specimens of esophageal adenocarcinoma from 73 patients were studied pathohistologically. The results demonstrated stage I in 1 cases; stage IIA 37; stage HB 8 and stage III 27. The incidence of postoperative complications and operative mortality were 4.1% and 1.4% respectively. The overall 5 year survival rate was 28. 3%. The authors pointed out that patients with primary esophageal adenocarcinoma should be operated on early. Even the late stage patients should also be treated surgically, because the esophageal adenocarcinoma is neither sensative to chemotherapy, nor radiotherapy.